Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
Neurology
When do you target the thalamus for SEEG exploration or neuromodulation in patients with drug-resistant epilepsy?
Related Questions
When do you consider pacing in arrhythmogenic epilepsy?
When do you use seizure prophylaxis in patients on clozapine?
When do you attribute tremors to lamotrigine?
When do you use wearable EEG or epilepsy detection devices for epilepsy management?
What markers on EEG can help predict/detect postoperative or ICU-related delirium?
How significant are the cardiovascular side effects, such as hypertension, associated with valproate?
When would you consider lacosamide for treatment of status epilepticus in patients with prolonged PR interval or first degree AV block?
When do you consider long-term anti-seizure medication for patients who have an acute symptomatic seizure in the setting of a cerebrovascular event?
What is the role for inpatient limited-montage EEG recording?
How often do you consider lamotrigine in patients with myoclonic epilepsy?
